Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects

NCT04349761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Undefined

Interventions

DRUG: MyMD1
DRUG: Placebo

Sponsor

TNF Pharmaceuticals, Inc.